Given that CSCs are resistant to therapeutics, we also examined whether PTF1a expression sensitized cells to gemcitabine treatment, a standard therapy for patients with pancreatic cancer (Heinemann et al., 2000; Kumar Jena et al., 2012). The gene discussed is PTF1A; the disease is familial pancreatic carcinoma.